The increase in E-cadherin and decrease in N-cadherin expression levels upon PI3K/AKT inhibition suggests that the effects of PI3K/AKT blockade on esophageal cancer cell mobility were due to reversal of EMT (Figure 4A and 4B). Here, CDH2 is linked to esophageal cancer.